The slip
PARKINSON RECEIPTno. 6883
22 Oct 2026, 22:39 UTCdopamine neurons, braak
predictionTLR10 in dopamine neurons tracks Braak Lewy-body stage
registered83abd4533668c80c
discovery-0.02 p=0.964 n=9
replication-0.50 p=0.172 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.02, p 0.964)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT8b9a4579020fd55b30ba5626…
follows 7d89dbd8aae3…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 6883: TLR10 in dopamine neurons, braak
- power
- full sample -0.14 (p 0.585, n 18), 95% CI -0.57 to +0.35. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.15 (p 0.555, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.31 (p 0.207, n 18). could be the mix.
- skeptic
- leave-one-out range -0.27 to -0.04, sign flips 0; without severely affected donors -0.14 (p 0.585, n 18). fragile.
- cell type
- strongest in microglia: -0.61 (p 0.0069, n 18) vs -0.14 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for TLR10 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up TLR10 · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.30 p 0.286 (needs p < 3.0e-4)